12-50843092-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182559.3(TMPRSS12):c.128A>T(p.Gln43Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000253 in 1,583,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182559.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMPRSS12 | NM_182559.3 | c.128A>T | p.Gln43Leu | missense_variant | 1/5 | ENST00000398458.4 | NP_872365.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMPRSS12 | ENST00000398458.4 | c.128A>T | p.Gln43Leu | missense_variant | 1/5 | 1 | NM_182559.3 | ENSP00000381476.3 | ||
TMPRSS12 | ENST00000551456.5 | c.128A>T | p.Gln43Leu | missense_variant | 1/4 | 2 | ENSP00000447259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000102 AC: 2AN: 196188Hom.: 0 AF XY: 0.0000189 AC XY: 2AN XY: 105846
GnomAD4 exome AF: 0.0000245 AC: 35AN: 1430690Hom.: 0 Cov.: 32 AF XY: 0.0000339 AC XY: 24AN XY: 708708
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.128A>T (p.Q43L) alteration is located in exon 1 (coding exon 1) of the TMPRSS12 gene. This alteration results from a A to T substitution at nucleotide position 128, causing the glutamine (Q) at amino acid position 43 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at